Having separated those patients with global or generalized spasticity who would benefit from oral medications, physical and occupational therapy - and in most cases specialized orthoses - from those with focal spasticity after the first evaluation, or from follow-up consultations, we We must ask the following questions: Are we complying with the proposed goals for treatment? Are we only replenishing the use of oral medication and are we static in the progression?
After completing the rehabilitation program (TF / TO), have the objectives been met or the doctor and / or patient want to continue working on the symptoms? Is there a contraindication for the other treatments?
These questions will give us an idea of what is happening with our patient, and we will know if it is necessary to climb a step in the complexity of the management.
Botulinum toxin is derived from the bacterium that causes botulism (Clostridium botulinum), which is a disease that produces flaccid muscular paralysis (the opposite of spasticity), so it was identified more than 30 years ago for the treatment of it. , becoming the current medicine in the first line of treatment for focal spasticity.
Being this an extremely powerful toxin, it has risks that are handled with proper training and respecting the therapeutic margins of application for each age and weight. In addition to planning clear goals, with understanding by the patient of what is pursued, and of course, accompanying coadjuvant treatments such as physical and occupational therapy, and serial splinting in cases where necessary.
Published in: Today Digital Newspaper